• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER MULTI-FENESTRATED SEPTAL OCCLUDER - CRIBRIFORM; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER MULTI-FENESTRATED SEPTAL OCCLUDER - CRIBRIFORM; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-ASD-MF-025
Device Problem Difficult to Fold, Unfold or Collapse (1254)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/06/2023
Event Type  malfunction  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Na.
 
Event Description
It was reported that on 6 november 2023, a 25 mm amplatzer cribriform septal occluder was chosen for implantation utilizing a 8f amplatzer trevisio delivery system.During deployment of the e atrium disc, it appeared convex and bulged.The device was removed and placed in warm saline solution but the deformation did not resolve.A replacement 25 mm amplatzer cribriform septal occluder was used to complete the procedure successfully.Interaction with cardiac structures occurred.There was no angulation or kink in the delivery system.There were no patient consequences and no clinically significant delay.The patient remained hemodynamically stable throughout the procedure and was reported to be recovered and stable.
 
Manufacturer Narrative
An event of device deformity during deployment was reported.Information from the field indicated that the correct size delivery sheath was used and that there was no angulation or kink in the delivery system.A returned device assessment could not be performed as the device was not returned for analysis.Four images were received from field.Two images appeared to show bulbously deployed distal disc of an occluder device outside patient.One of the four images showed occluder device connected to the delivery cable outside patient.Last image appeared to be taken during imaging.The distal disc appeared bulbously deployed during deployment.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Manufacturer Narrative
An event of device deformity during deployment was reported.The investigation confirmed the device met functional specifications when analyzed at abbott under non-physiological conditions.Two images from field appeared to show bulbously deployed distal disc of an occluder device outside patient.One of the four images showed occluder device connected to the delivery cable outside patient.Last image appeared to be taken during imaging.The distal disc appeared bulbously deployed during deployment.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Event Description
It was reported that on (b)(6) 2023, a 25 mm amplatzer cribriform septal occluder was chosen for implantation utilizing a 8f amplatzer trevisio delivery system.During deployment of the e atrium disc, it appeared convex and bulged.The device was removed and placed in warm saline solution but the deformation did not resolve.A replacement 25 mm amplatzer cribriform septal occluder was used to complete the procedure successfully.Interaction with cardiac structures occurred.There was no angulation or kink in the delivery system.There were no patient consequences and no clinically significant delay.The patient remained hemodynamically stable throughout the procedure and was reported to be recovered and stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER MULTI-FENESTRATED SEPTAL OCCLUDER - CRIBRIFORM
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18241873
MDR Text Key329462241
Report Number2135147-2023-05276
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010298
UDI-Public(01)00811806010298(17)271031(10)8744121
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number9-ASD-MF-025
Device Lot Number8744121
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/30/2023
Supplement Dates Manufacturer Received01/03/2024
04/24/2024
Supplement Dates FDA Received01/10/2024
05/16/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AMPLATZER TREVISIO
Patient SexFemale
-
-